Drawing for SYNCSLEEP

USPTO serial 97585442

SYNCSLEEP

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
RITTNER, HANNO I
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SYNCSLEEP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

RICHARD S. FINKELSTEIN

RICHARD S. FINKELSTEIN RC TRADEMARK COMPANY, LLCP.O. BOX 940BROOKFIELD, CT 06804UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Drugs for medical use based on melatonin for the treatment of sleep disturbances, insomnia; Drugs for medical treatment of sleep disturbances; Drugs for treatment of insomnia; Melatonin drugs, namely, sleep aid preparations; Pharmaceuticals for the treatment of sleep disturbances; Pharmaceutical drugs for the treatment of sleep disturbances, insomnia; Pharmaceutical preparations for the prevention of sleep disturbances; Therapeutic drugs for the treatment of sleep disturbances; Natural pharmaceutical preparations for the treatment of sleep disturbances; Medical preparations for humans based on melatonin for the treatment of sleep disturbances, insomnia; Medicines for the treatment of insomnia; Medicines for the treatment of sleep disturbanceABANDONED—
010Medical diagnostic apparatus for patient treatment, namely, apparatus for measuring sleep, wakefulness states, circadian rhythms; Medical devices for diagnosing patients for treatment, namely, devices for measuring sleep, wakefulness states, circadian rhythms; Electro medical instruments for measuring sleep, wakefulness states, circadian rhythms for diagnosing patient disorders for further treatment; Medical testing instruments for measuring sleep, wakefulness states, circadian rhythms for diagnoses of patient disorders for further treatment; Medical instruments for measuring sleep, wakefulness states, circadian rhythms for diagnoses of patient disorders for further treatment; Electronic monitoring instruments for medical use for measuring sleep, wakefulness states, circadian rhythms for diagnoses of patient disorders for further treatment; Replacement parts and fittings for all of the aforesaid goodsABANDONED—
044Healthcare; Healthcare consultancy; Healthcare services; Healthcare information services; Healthcare advisory services; Health clinical services; Health screening services in the field of sleep disturbances; Medical health assessment services, namely, providing advice on timing of sleep, wake schedules, timing of taking of medications; Sleep disorder treatment therapy services; Monitoring of patients, namely, clinical medical consultation services; Individual medical counseling services provided to patients; Medical care, and wakefulness states and circadian rhythms analysis services relating to patient treatment; Healthcare counselling; Preparation of reports relating to health care matters, namely, reporting of consumer authorized clinical testing results directly to the patient; Providing medical information; Information and advisory related to all of the aforesaid servicesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 11, 2024MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Oct 11, 2024ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Oct 11, 2024OP.TOPPOSITION TERMINATED NO. 999999—
Oct 11, 2024OP.SOPPOSITION SUSTAINED NO. 999999—
Jul 20, 2024ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jul 11, 2024OP.IOPPOSITION INSTITUTED NO. 999999—
Jun 14, 2024ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 21, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 1, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 9, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 9, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 9, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 29, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 29, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 29, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 27, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2024ALIEASSIGNED TO LIE—
Oct 5, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 5, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 5, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 5, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2023DOCKASSIGNED TO EXAMINER—
Sep 27, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 13, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance